Related Experiment Video
Updated: Aug 19, 2026

An Optimized Enrichment Technique for the Isolation of Arthrobacter Bacteriophage Species from Soil Sample Isolates
Published on: April 9, 2015
Isolation and characterization of novel giant Stenotrophomonas maltophilia phage phiSMA5
Hsiao-Chuan Chang1, Chiy-Rong Chen, Juey-Wen Lin
1Institute of Molecular Biology, National Chung Hsing University, Taichung 402, Taiwan.
Abstract:
Stenotrophomonas maltophilia is one of the most prevalent opportunistic bacteria causing nosocomial infections. It has become problematic because most of the isolates are resistant to multiple antibiotics, and therefore, development of phage therapy has attracted strong attention. In this study, eight S. maltophilia phages were isolated from clinical samples including patient specimens, catheter-related devices, and wastewater. These phages can be divided into four distinct groups based on host range and digestibility of the phage DNAs with different restriction endonucleases. One of them, designated phiSMA5, was further characterized. Electron microscopy showed it resembled Myoviridae, with an isometric head (90 nm in diameter), a tail (90 nm long), a baseplate (25 nm wide), and short tail fibers. The phiSMA5 double-stranded DNA, refractory to digestion by most restriction enzymes, was tested and estimated to be 250 kb by pulsed-field gel electrophoresis. This genome size is second to that of the largest phage, phiKZ of Pseudomonas aeruginosa. In sodium dodecyl sulfate-polyacrylamide gel electrophoresis, 25 virion proteins were visualized. N-terminal sequencing of four of them suggested that each of them might have had its N terminus cleaved off. Among the 87 S. maltophilia strains collected in this study, only 61 were susceptible to phiSMA5, indicating that more phages are needed toward a phage therapy strategy. Since literature search yielded no information about S. maltophilia phages, phiSMA5 appears to be the first reported.
Insights
Researchers isolated eight Stenotrophomonas maltophilia phages from clinical samples. One phage, phiSMA5, was characterized, showing potential for phage therapy against antibiotic-resistant bacteria.
Area of Science:
- Microbiology
- Bacteriology
- Virology
Background:
- Stenotrophomonas maltophilia is a prevalent opportunistic pathogen causing nosocomial infections.
- Antibiotic resistance in S. maltophilia necessitates alternative therapeutic strategies like phage therapy.
Purpose of the Study:
- To isolate and characterize bacteriophages targeting Stenotrophomonas maltophilia.
- To evaluate the potential of isolated phages for phage therapy applications.
Main Methods:
- Isolation of phages from clinical samples (patient specimens, devices, wastewater).
- Phage grouping based on host range and DNA digestion patterns.
- Characterization of phage phiSMA5 using electron microscopy, restriction enzyme analysis, pulsed-field gel electrophoresis, and SDS-PAGE.
- N-terminal sequencing of virion proteins.
Main Results:
- Eight S. maltophilia phages were isolated and classified into four groups.
- Phage phiSMA5, resembling Myoviridae, possesses a 250 kb double-stranded DNA genome.
- SDS-PAGE revealed 25 virion proteins, with some showing N-terminal cleavage.
- phiSMA5 infected 61 out of 87 tested S. maltophilia strains.
Conclusions:
- phiSMA5 is the first reported bacteriophage targeting Stenotrophomonas maltophilia.
- Further phage isolation and characterization are crucial for developing effective phage therapy strategies against S. maltophilia.
Related Concept Videos
Bacterial Phylum Tenericutes
DNA Bacteriophages

